BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2507827)

  • 1. The c-myc oncogene is regulated independently of differentiation in myeloid cell lines.
    Roberts P; Jones M; Gale R; Thomas S; Tidman N; Linch D
    Leuk Res; 1989; 13(8):651-9. PubMed ID: 2507827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry.
    Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A
    Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription interruption may be a common mechanism of c-myc regulation during HL-60 differentiation.
    McCachren SS; Salehi Z; Weinberg JB; Niedel JE
    Biochem Biophys Res Commun; 1988 Feb; 151(1):574-82. PubMed ID: 3126739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells.
    Hoffman-Liebermann B; Liebermann DA
    Oncogene; 1991 Jun; 6(6):903-9. PubMed ID: 1906157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
    Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
    Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
    Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and transient decrease of N-myc expression in retinoic acid-induced differentiation of OTF9 teratocarcinoma stem cells.
    Kato K; Kanamori A; Kondoh H
    Mol Cell Biol; 1990 Feb; 10(2):486-91. PubMed ID: 2405249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
    Weinberg JB; Mason SN
    Cancer Res; 1991 Feb; 51(4):1202-9. PubMed ID: 1997162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.
    Yuh YS; Thompson EB
    J Biol Chem; 1989 Jun; 264(18):10904-10. PubMed ID: 2659598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene.
    Pape KA; Floyd-Smith G
    Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells.
    Trepel JB; Colamonici OR; Kelly K; Schwab G; Watt RA; Sausville EA; Jaffe ES; Neckers LM
    Mol Cell Biol; 1987 Jul; 7(7):2644-8. PubMed ID: 3039354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between the cell cycle and the expression of c-myc and transferrin receptor genes during induced myeloid differentiation.
    Barker KA; Newburger PE
    Exp Cell Res; 1990 Jan; 186(1):1-5. PubMed ID: 2404770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 1-beta-D-arabinofuranosylcytosine on proto-oncogene expression in human U-937 cells.
    Mitchell T; Sariban E; Kufe D
    Mol Pharmacol; 1986 Oct; 30(4):398-402. PubMed ID: 3531806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma inhibits c-myc gene expression by impairing the splicing process in a colony-stimulating factor dependent murine myeloid cell line.
    Harel-Bellan A; Brini AT; Farrar WL
    J Immunol; 1988 Aug; 141(3):1012-7. PubMed ID: 3135308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associated with down-regulation of c-myc.
    Mata-Greenwood E; Cuendet M; Sher D; Gustin D; Stock W; Pezzuto JM
    Leukemia; 2002 Nov; 16(11):2275-84. PubMed ID: 12399973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 5-aza-2'-deoxycytidine and retinoic acid on differentiation and c-myc expression in HL-60 myeloid leukemic cells.
    Momparler RL; Doré BT; Momparler LF
    Cancer Lett; 1990 Oct; 54(1-2):21-8. PubMed ID: 1698532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continued withdrawal from the cell cycle and regulation of cellular genes in mouse erythroleukemia cells blocked in differentiation by the c-myc oncogene.
    Coppola JA; Parker JM; Schuler GD; Cole MD
    Mol Cell Biol; 1989 Apr; 9(4):1714-20. PubMed ID: 2657403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
    Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
    Anfossi G; Gewirtz AM; Calabretta B
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3379-83. PubMed ID: 2541445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.